


| Key | % Net Assets |
|---|---|
| 3.2% | |
| 2.1% | |
| 2.0% | |
| 2.0% | |
| 90.7% |
| Name | % Net Assets |
|---|---|
| AstraZeneca | 3.2% |
| Centrica | 2.1% |
| France Telecom 7.25% 10/11/20 | 2.0% |
| British Telecom 7.5% VRN 07/12/16 | 2.0% |
| GlaxoSmithKline | 2.0% |
| Hutchison Ports Finance 6.75% 07/12/15 | 2.0% |
| BP | 1.9% |
| Roche Finance Europe 5.375% 29/08/23 | 1.9% |
| Vodafone | 1.9% |
| Tesco 5.5% 13/12/19 | 1.8% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 115.97p |
| Currency | GBP |
| Change | 0.010p |
| % | 0.01% |
| YTD change | 6.47p |
| YTD % | 5.91% |
| Fund Inception | 04/03/2002 |
|---|---|
| Fund Manager | n/a |
| TER | 1.39 (31-Oct-2013) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | £100 |
| Charges | |
|---|---|
| Initial | 4.50% |
| Annual Mang't | 1.25% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.13 |
You are here: research